Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-20-046134

SVP, Finance and CFO sold 22,554 shares at $48.00 ($1,082,592)

  • SVP, Finance and CFO acquired 29,804 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cotroneo Pat · SVP, Finance and CFO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-07 Exercise or conversion : show line 1 in the form +22,554 $19.39 $437,322 293,614 D
2020-08-07 Sale : show line 2 in the form −22,554 $48.00 $1,082,592 271,060 D
2020-08-11 Exercise or conversion : show line 3 in the form +3,750 $19.39 $72,713 274,810 D
2020-08-11 Exercise or conversion : show line 4 in the form +3,500 $18.00 $63,000 278,310 D
Open-market sales · 22,554 sh · avg $48.00 · $1,082,592

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-08-07 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −22,554 $19.39 2026-02-22 22,554 9,446 D
2020-08-11 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −3,750 $19.39 2026-02-22 3,750 5,696 D
2020-08-11 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −3,500 $18.00 2024-11-13 3,500 0 D
Loading xslF345X03/doc4.xml…